CD4 and Guillain-Barre syndrome: It has been shown that patients with GBS treated with lymphoid progenitor exchange (LPE) have a significant decrease in the percentage of Th1 and Th17 cells and an increase in Th2 and Treg cells in the peripheral blood among the CD4+ T-lymphocyte subsets (18).